HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Fragrance Firms Explore Opportunities With oPhone “Scent Messaging”

This article was originally published in The Rose Sheet

Executive Summary

Vapor Communications, creators of the oPhone, say the scent-based mobile messaging technology could refine the consumers scent palette and provide new opportunities for fragrance industry in the near future. The oPhone platform consists of a website (oNotes.com), an app (oSnap) and products that can be experienced at oPhone “hotspot” docking stations in Paris, New York and Cambridge, Mass.

You may also be interested in...



Fragrance Fringe and Future: ‘Visual’ Scents, Wearable Enhancers And Smart Diffusers

In today’s digital world, a growing crop of innovators are working to stoke renewed interest in fragrance and overcome market barriers by digitizing, accessorizing or multi-dimensionalizing the scent experience.

Claim That Supplement Boosts Children’s Focus Could Spur FTC Attention

Creekside Natural Therapeutics might hear from the FTC after failing to show in an industry self-regulation forum that it would correct misleading claims for its Focused Mind Jr. supplement promoted as an alternative to ADHD drugs.

FDA Gets Message In Congress' First Cannabis Policy Hearing: Deliver CBD Regulation

During first-ever congressional hearing on federal policies for lawful use of cannabis, House Energy and Commerce Health Subcommittee Chairwoman Anna Eschoo says with $2m appropriated to develop a regulation on CBD’s use in non-drug products during, FDA should deliver.

UsernamePublicRestriction

Register

RS019114

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel